|
Cancer and Women''s Health Interagency Agreement
|
Research Initiative
|
FDA
|
NCI
|
The overall purpose of this NCI/FDA collaboration is to promote the public health of all women through advancements in cancer research and medical therapies. The parties envision this joint collaborative activity to encompass all the major cancers afflicting the health and well-being for adult women.
|
|
Cancer Control and Cancer Survivorship in the Sister Studies
|
Health Survey
|
CDC
|
NIEHS
|
Activities include holding a workshop on research priorities for understanding breast cancer in young women and conducting 2 surveys within the Sister Study: 1) looking at high risk women without breast cancer to understand the impact of breast cancer in a family member on women and their daughters, including screening and lifestyle behaviors; and 2) a survey of young breast cancer survivors to identify issues related to treatment and follow-up, barriers to care, quality of life, discrimination, and other factors post-diagnosis. The study focuses on special needs of young survivors, including fertility.
|
|
Cancer Control Plan, Link, Act, Network with Evidence-Based Tools (P.L.A.N.E.T)
|
Resource Development
|
AHRQ, CDC, SAMHSA
|
NCI
|
Cancer control planners, program staff, and researchers have the same goals: to reduce cancer risk, the number of new cancer cases, and the number of deaths from cancer, as well as enhance the quality of life for cancer survivors. While many share the same goals, all do not have easy access to resources that can facilitate the transfer of evidence-based research findings into practice. This Cancer Control P.L.A.N.E.T. (Plan, Link, Act, Network with Evidence-based Tools) portal provides access to data and resources that can help planners, program staff, and researchers to design, implement and evaluate evidence-based cancer control programs.
|
|
Cardiovascular Coordination Team
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NHLBI
|
The purpose of the workgroup is to assess the feasibility of conducting an evidence based review to assess the effectiveness of interventions using community health workers for cardiovascular disease prevention. The final review will be included in The Community Guide sponsored by the Community Preventive Services Task Force.
|
|
Carrier Screening Work Group
|
Committee, Work group, Advisory group, or Task Force
|
HRSA
|
NICHD
|
The purpose of the committee is to make recommendations to the Secretary''s Advisory Committee for Heritable Disorders in infants and children related to screenable disorder.
|
|
CDC Chronic Kidney Disease Surveillance
|
Health Survey
|
CDC
|
NIDDK
|
NIDDK assists CDC in their surveillance program of chronic kidney disease.
|
|
CDC Community Guide: Review Various Interventions to Reduce Alcohol-Related Problems
|
Resource Development
|
CDC, SAMHSA
|
NIAAA, NIDA
|
The Community Guide is a free resource to help people choose the most effective programs and policies to improve health and prevent disease in their communities.
|
|
CDC Elimination of Pediatric HIV in US Stakeholders Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NICHD
|
Working group of federal and non-federal individuals to assist the Centers for Disease Control and Prevention (CDC) in developing initiatives to eliminate mother to child HIV transmission in the US.
|
|
CDC Pediatric HIV Case Definition Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NICHD
|
Advises on development of new pediatric HIV surveillance definitions.
|
|
CDC-NIH Lyme Disease Serum Sample Repository
|
Resource Development
|
CDC, OS
|
NIAID
|
Initiated in 2008, this resource was made available to the scientific community on a broad basis in late 2011. Lyme disease and related serum samples are available upon request for testing and comparison of new and current diagnostic tests with a common serum sample set for standardization. Samples are distributed by the CDC. CDC and NIH both provided support to acquire the samples and continue to work together to ensure the scientific community has access to samples needed for Lyme disease diagnostic test development.
|